NTRK2-FUSIONEN

Patent europeic · EP3027655 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3027655
Numer da la dumonda
EP14750923
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
30-07-2014
Publitgà
08-06-2016
Concedì
21-08-2019
Stritgà
31-07-2020
Motiv
Taxa annuala betg pajada
Classas IPC
C07K 16/40 (2006.01)
C12Q 1/48 (2006.01)
C12Q 1/68 (2018.01)
Prioritad
US 201361860153 P 30.07.2013
US 201461943028 P 21.02.2014
Dumonda PCT
PCT/US2014/048881 30.07.2014
Publicaziun PCT
WO2015/017533 05.02.2015
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 17-02-2021

    Stritgà, taxa betg pajada

    Published in Swissreg on 17.02.2021

  2. 21-08-2019

    Concedì

    Published in Swissreg on 21.08.2019

Partidas

Possessur

Blueprint Medicines Corporation

38 Sidney Street, suite 200, Cambridge, MA 02139, US

Inventur

LENGAUER, Christoph

Cambridge, MA 02140, US

STRANSKY, Nicolas

Charlestown, MA 02129, US

CERAMI, Ethan G.

Winchester, MA 01890, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.